Restaging during radiotherapy classified 9 patients as stage I, 28 as IIA, 13 as IIB, 5 as IIIA, and 9 as IIIB. The 5-year overall survival rate was 81% and the 5-year relapse-free survival rate 75.8%.

• 放疗中再分期结果:I期9例；IIA期28例；IIB期13例；IIIA期5例；IIIB期9例。 全组累计5年生存率和无瘤生存率分别为81%25和75.；8%25。